Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

569 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 569 results

Early research (Phase 1)Study completedNCT05427253
What this trial is testing

First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

Who this might be right for
Safety IssuesToleranceIdiopathic Pulmonary Fibrosis+1 more
Vicore Pharma AB 80
Testing effectiveness (Phase 2)WithdrawnNCT04244825
What this trial is testing

Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Blade Therapeutics
Not applicableStudy completedNCT04803617
What this trial is testing

Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisSarcoidosis, Pulmonary+1 more
Habibedurdu 68
Not applicableStudy completedNCT02055222
What this trial is testing

Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease

Who this might be right for
Pulmonary FibrosisLung Disease
National Heart, Lung, and Blood Institute (NHLBI) 7
Not applicableStudy completedNCT03115619
What this trial is testing

Quality of Life Study in Participants With IPF Under Pirfenidone Treatment

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 102
Early research (Phase 1)Study completedNCT04888728
What this trial is testing

To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co. LTD. 24
Very early researchLooking for participantsNCT05365802
What this trial is testing

FAPI PET for Lung Fibrosis

Who this might be right for
Interstitial Lung DiseaseIdiopathic Interstitial PneumoniasDrug-Induced Pneumonitis+4 more
University of California, Los Angeles 30
Not applicableStudy completedNCT00512967
What this trial is testing

The Occurence of Inflammation and Oxidative Stress in Lung Diseases

Who this might be right for
Interstitial Lung DiseasesSarcoidosisIdiopathic Pulmonary Fibrosis+1 more
Maastricht University Medical Center 76
Not applicableLooking for participantsNCT01915511
What this trial is testing

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Who this might be right for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Duke University 3,000
Not applicableStudy completedNCT05173571
What this trial is testing

Homecare Integral Support Program for IPF Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Institut d'Investigació Biomèdica de Bellvitge 95
Not applicableStudy completedNCT01462006
What this trial is testing

Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisDiffuse Parenchymal Lung DiseaseInterstitial Lung Disease
University of Virginia 32
Testing effectiveness (Phase 2)Ended earlyNCT03287414
What this trial is testing

Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 30
Early research (Phase 1)Study completedNCT03650075
What this trial is testing

To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Metagone Biotech Inc. 81
Testing effectiveness (Phase 2)Study completedNCT02503657
What this trial is testing

Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisIPF
MediciNova 15
Not applicableLooking for participantsNCT03297775
What this trial is testing

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
University of Colorado, Denver 750
Testing effectiveness (Phase 2)Study completedNCT04072315
What this trial is testing

Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/

Who this might be right for
Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc. 9
Not applicableLooking for participantsNCT06909409
What this trial is testing

D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
University of Aarhus 120
Not applicableStudy completedNCT01118221
What this trial is testing

Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
US Department of Veterans Affairs 25
Testing effectiveness (Phase 2)Ended earlyNCT03562416
What this trial is testing

Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects

Who this might be right for
Idiopathic Pulmonary FibrosisLung Transplant; Complications
Temple University 1
Not applicableLooking for participantsNCT06162884
What this trial is testing

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University of California, Los Angeles 200
Load More Results